Moderna (MRNA) Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/4/2026

1. KRG
2. PRY:IM
3. PRYMY
4. SPY
5. SKA-B
6. PBA
7. ALAR
8. CCH:LN
9. META
10. CCHGY

Go back to Moderna (MRNA) Announces Positive Top Line Data from Phase 2/3 Study of COVID-19 Vaccine in Children 6 to 11 Years of Age
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 79.76 +7.26 (10.01%)
Previous Close $72.50    52 Week High $0.52 
Open $73.71    52 Week Low $0.08 
Day High $81.40    P/E N/A 
Day Low $73.68    EPS $-3.80 
Volume 14,112,278